Company / Operating Income
Q32 Bio Inc. Operating Income History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$66.1M
FY2025
5-year range
-$133.3M / -$48.3M
FY2021-FY2025
Trend
-37.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income has fluctuated over the past 8 years, ranging from -$133M in FY2023 to -$30M in FY2018.
Based on SEC 10-K filings.
-$66M in FY2025.
Improved from -$133M to -$66M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income decreased 37.0% year-over-year.
- Peak operating income was recorded in FY2018.
- Lowest operating income in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -2.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$66.1M | -37.0% |
| FY2024 | -$48.3M | +63.8% |
| FY2023 | -$133.3M | -38.9% |
| FY2022 | -$95.9M | +26.3% |
| FY2021 | -$130.3M | -18.5% |
| FY2020 | -$109.9M | -83.5% |
| FY2019 | -$59.9M | -102.1% |
| FY2018 | -$29.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026